We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-13.14%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$2.89B
AUM Growth
-$1.67B
Cap. Flow
-$1.03B
Cap. Flow %
-35.56%
Top 10 Hldgs %
86.48%
Holding
52
New
4
Increased
10
Reduced
10
Closed
7

Top Buys

Rank Stock Value
1
WNS
WNS Holdings
WNS
+$75.6M
2
API
Agora
API
+$8.61M
3
BEKE icon
KE Holdings
BEKE
+$8.09M
4
FUTU icon
Futu Holdings
FUTU
+$6.29M
5
TSM icon
TSMC
TSM
+$4.49M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$372M
2
ONC
BeOne Medicines Ltd
ONC
+$280M
3
PDD icon
Pinduoduo
PDD
+$237M
4
TCOM icon
Trip.com Group
TCOM
+$56.9M
5
ZTO icon
ZTO Express
ZTO
+$56.3M

Sector Composition

Rank Sector Weight
1 Healthcare 39.96%
2 Consumer Discretionary 34.86%
3 Communication Services 8.29%
4 Real Estate 7.18%
5 Technology 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$33.9B
$703M 24.34%
3,804,406
-1,372,500
-27% -$280M
BABA icon
2
Alibaba
BABA
$275B
$414M 14.35%
4,887,300
-3,940,300
-45% -$372M
PDD icon
3
Pinduoduo
PDD
$124B
$265M 9.17%
2,730,275
-2,036,505
-43% -$237M
NTES icon
4
NetEase
NTES
$82.7B
$231M 8%
2,588,943
– –
BEKE icon
5
KE Holdings
BEKE
$17.7B
$207M 7.18%
11,261,276
+392,588
+4% +$8.09M
VIPS icon
6
Vipshop
VIPS
$7.19B
$200M 6.94%
14,880,002
-840,320
-5% -$12.1M
LEGN icon
7
Legend Biotech
LEGN
$3.68B
$195M 6.74%
5,984,550
-651,946
-10% -$27M
AVBP icon
8
ArriVent BioPharma
AVBP
$1.4B
$119M 4.14%
4,484,672
– –
FUTU icon
9
Futu Holdings
FUTU
$14.4B
$89.5M 3.1%
1,118,303
+67,214
+6% +$6.29M
WNS
10
DELISTED
WNS Holdings
WNS
$72.6M 2.51%
+1,531,466
New +$75.6M
TCOM icon
11
Trip.com Group
TCOM
$29.4B
$62.7M 2.17%
913,842
-860,590
-48% -$56.9M
JD icon
12
JD.com
JD
$43.3B
$58.6M 2.03%
1,690,000
+90,000
+6% +$3.48M
ENFN
13
DELISTED
Enfusion, Inc.
ENFN
$51.2M 1.77%
4,975,183
– –
CTKB icon
14
Cytek Biosciences
CTKB
$575M
$43.2M 1.5%
6,657,030
– –
KNSA icon
15
Kiniksa Pharmaceuticals
KNSA
$6.12B
$31.3M 1.08%
1,582,635
– –
BBIO icon
16
BridgeBio Pharma
BBIO
$16.6B
$28.1M 0.97%
1,023,950
– –
YSG
17
Yatsen Holding
YSG
$314M
$27.4M 0.95%
6,885,873
-101,966
-1% -$421K
CTNM
18
Contineum Therapeutics
CTNM
$528M
$9.81M 0.34%
669,337
– –
API
19
Agora
API
$335M
$8.73M 0.3%
+2,098,553
New +$8.61M
ZTO icon
20
ZTO Express
ZTO
$18.4B
$8.52M 0.3%
435,927
-2,567,081
-85% -$56.3M
TSM icon
21
TSMC
TSM
$1.99T
$8.41M 0.29%
42,588
+23,193
+120% +$4.49M
SOHU
22
Sohu.com
SOHU
$331M
$6.73M 0.23%
510,484
-202,916
-28% -$2.83M
NBP
23
NovaBridge Biosciences American Depositary Shares
NBP
$195M
$5.08M 0.18%
5,980,568
-928,652
-13% -$1.03M
GOSS icon
24
Gossamer Bio
GOSS
$91.2M
$4.5M 0.16%
4,974,041
– –
SGMT icon
25
Sagimet Biosciences
SGMT
$445M
$3.26M 0.11%
724,800
– –
1
2 3

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, HHLR Advisors held 52 positions worth $2.89B, down 37% from $4.56B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

HHLR Advisors withdrew a net $1.03B in Q4 2024, closing 7 positions and reducing 10 holdings. Its most notable exit was Baidu, an estimated $31.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, HHLR Advisors opened a new position in WNS Holdings worth $72.6M.

  • HHLR Advisors's largest Q4 2024 buy was WNS Holdings: 1,531,466 shares worth $72.6M.
  • HHLR Advisors added most to KE Holdings in Q4 2024, an estimated $8.09M increase.
  • HHLR Advisors's biggest Q4 2024 reduction was Alibaba, cutting an estimated $372M.
  • HHLR Advisors fully exited Baidu in Q4 2024, selling an estimated $31.6M.
  • HHLR Advisors's ten largest holdings make up 86% of its $2.89B portfolio in Q4 2024.
  • HHLR Advisors opened 4 new positions and closed 7 in Q4 2024.
  • HHLR Advisors's portfolio value fell 37% quarter-over-quarter to $2.89B.

Based on HHLR Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.